Agenus Inc.(AGEN)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-02-15 | ARMEN GARO H See Remarks | Purchase | +500,000 | +396.92%625,969 | $0.65 | $324,050 | View SEC filing | |
| 2023-11-17 | WIINBERG ULF Director | Purchase | +25,000 | +25.24%124,063 | $0.76 | $19,000 | View SEC filing | |
| 2022-01-06 | O'Day Steven J Chief Medical Officer | Sale | -38,679 | -38.68%61,321 | $3.06 | $118,346 | View SEC filing | |
| 2021-09-14 | ARMEN GARO H Chairman and CEO | Sale | -82,107 | -9.63%770,773 | $6.50 | $533,696 | View SEC filing | |
| 2021-09-14 | KLASKIN CHRISTINE M PFO & PAO | Sale | -11,120 | -10.67%93,056 | $6.50 | $72,280 | View SEC filing | |
| 2020-06-18 | INCYTE CORP 10% Owner | Sale | -214,000 | -1.25%16,972,968 | $3.66 | $782,839 | View SEC filing | |
| 2020-06-15 | INCYTE CORP 10% Owner | Sale | -577,000 | -3.25%17,186,968 | $3.64 | $2,097,502 | View SEC filing | |
| 2017-12-14 | Baysal Ozer Chief Commercial Officer | Sale | -3,712 | -5.94%58,790 | $3.46 | $12,846 | View SEC filing | |
| 2017-12-14 | Buell Jennifer Chief Communications Officer | Sale | -3,511 | -8.96%35,656 | $3.46 | $12,152 | View SEC filing | |
| 2017-12-14 | Duncan Alex Chief Technology Officer | Sale | -6,546 | -23.74%21,026 | $3.46 | $22,651 | View SEC filing | |
| 2017-12-14 | KLASKIN CHRISTINE M VP, Finance | Sale | -5,610 | -8.02%64,333 | $3.46 | $19,418 | View SEC filing | |
| 2017-12-14 | Valentine Karen Chief Legal Officer | Sale | -8,358 | -7.61%101,521 | $3.46 | $28,921 | View SEC filing | |
| 2017-10-31 | ARMEN GARO H Chairman & CEO | Purchase | +100,000 | +6.71%1,590,441 | $3.55 | $355,115 | View SEC filing | |
| 2017-04-12 | ARMEN GARO H Chairman & CEO | Purchase | +100,000 | +7.58%1,418,477 | $3.35 | $334,520 | View SEC filing | |
| 2017-02-14 | INCYTE CORP 10% Owner | Purchase | +10,000,000 | +128.80%17,763,968 | $6.00 | $60,000,000 | View SEC filing | |
| 2016-09-08 | WIINBERG ULF Director | Purchase | +30,000 | +100.00%30,000 | $6.29 | $188,700 | View SEC filing | |
| 2016-05-10 | ARMEN GARO H Chairman & CEO | Purchase | +100,000 | +7.72%1,396,026 | $3.18 | $317,895 | View SEC filing | |
| 2016-05-10 | ARMEN GARO H Chairman & CEO | Purchase | +100,000 | +7.72%1,396,026 | $3.18 | $317,895 | View SEC filing | |
| 2016-05-09 | Baysal Ozer Chief Business Officer | Purchase | +2,250 | +7.19%33,538 | $3.10 | $6,975 | View SEC filing | |
| 2016-03-08 | ARMEN GARO H Chairman & CEO | Purchase | +200,000 | +19.03%1,251,228 | $4.03 | $805,600 | View SEC filing | |
| 2015-12-30 | ARMEN GARO H Chairman & CEO | Sale | -219,576 | -15.32%1,213,228 | $4.59 | $1,007,877 | View SEC filing | |
| 2015-09-29 | ARMEN GARO H Chairman & CEO | Purchase | +100,000 | +7.64%1,409,607 | $5.03 | $503,000 | View SEC filing | |
| 2015-09-29 | Ballantyne Charles Evan Chief Financial Officer | Purchase | +10,000 | +100.00%10,000 | $5.05 | $50,500 | View SEC filing | |
| 2015-04-30 | Malik Shahzad Director | Sale | -1,107,377 | -100.00%0 | $7.11 | $7,871,369 | View SEC filing | |
| 2015-01-13 | QVT Associates GP LLC 10% Owner | Sale | -2,343,630 | -25.31%6,915,630 | $5.31 | $12,451,322 | View SEC filing |
1-25 of 96